Delivery Order SPE2DR25D9133-SPE2DR26FCFU1
Award Date 3/3/26
Potential Completion Date 3/24/26
Potential Value $63K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 25, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.9 billion ceiling supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for YF-VAX 1 dose vials, with ultimate completion March 27, 2026. This order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 25, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities...
- The Defense Logistics Agency issued a $25,181.60 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 27, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. Place of performance is...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for YF-VAX 1 dose vials, with a ceiling value of $1,888.62. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, for YF-VAX 1 dose vials, with a ceiling value of $3,147.70. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations. Place of...
- The Defense Logistics Agency issued a $62,954 delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, for YF-VAX 1 dose vials, with ultimate completion by March 16, 2026. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award indefinite delivery contract. Place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 25, 2026. The order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) single-award indefinite delivery contract (SPE2DR), a Defense Logistics Agency vehicle with a $499.9 billion ceiling through December 31, 2036. The PPV-G GEN V program authorizes firm...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 11, 2026. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) single-award indefinite delivery contract (SPE2DR), a firm fixed-price vehicle supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for YF-VAX 1 dose vials, with a ceiling value of $1,259.08. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that supplies pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small...